University of California San Francisco

Personalizing dermatology: the future of genomic expression profiling to individualize dermatologic therapy. (21254882)

Rizzo AE, Maibach HI PMID: 21254882

Psoriasis responds to intralesional injections of alefacept and may predict systemic response to intramuscular alefacept: interim results of a single-arm, open-label study. (21254875)

Gattu S, Busse K, Bhutani T, Chiang C, Nguyen T, Becker E, Koo JY PMID: 21254875

A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. (21255868)

Farasat S, Yu SS, Neel VA, Nehal KS, Lardaro T, Mihm MC, Byrd DR, Balch CM, Califano JA, Chuang AY, Sharfman WH, Shah JP, Nghiem P, Otley CC, Tufaro AP, Johnson TM, Sober AJ, Liégeois NJ PMID: 21255868

Safety profile of topical diclofenac: a meta-analysis of blinded, randomized, controlled trials in musculoskeletal conditions. (21231861)

Taylor RS, Fotopoulos G, Maibach H PMID: 21231861

Dislodgeable stratum corneum exfoliation: role in percutaneous penetration? (21226557)

Zheng Y, Vieille-Petit A, Chodoutaud S, Maibach HI PMID: 21226557

Immune reconstitution inflammatory syndrome and tropical dermatoses. (21095526)

Amerson EH, Maurer TA PMID: 21095526

NF-κB and innate immunity. (20848362)

Dev A, Iyer S, Razani B, Cheng G PMID: 20848362

Regional treatment strategies for in-transit melanoma metastasis. (21111960)

Turley RS, Raymond AK, Tyler DS PMID: 21111960

Hydroxyurea for the Treatment of Psoriasis including in HIV-infected Individuals: A Review. (25346593)

Lee ES, Heller MM, Kamangar F, Park K, Liao W, Koo J PMID: 25346593

Hydroxyurea for the Treatment of Psoriasis including in HIV-infected Individuals: A Review. (25346593)

Lee ES, Heller MM, Kamangar F, Park K, Liao W, Koo J PMID: 25346593